LLY Stock Price, News and Analysis
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market Cap: $839,282,495,367.4
Industry: PHARMACEUTICAL PREPARATIONS
Track LLY stock with real-time alerts and market analysis
Current Price: $940.06
Eli Lilly and Company
LLY•United States
$940.06
-1.47%$-14.00
Day Range
$935.54-$963.94
Volume
1.9M
Avg Volume
4.4K
Market News
58s@marketnews
Major market announcement affects tech stocks across all sectors
Was this helpful?
Earnings Report
April 11 at 6:28 PM@earnings
Earnings report shows significant growth in quarterly revenue
Was this helpful?
Regulatory Filing
April 10 at 6:28 PM@regulatory
Regulatory changes impact industry outlook for upcoming quarter
Was this helpful?